UK Markets close in 11 mins

Evolva Holding SA (0QQJ.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
0.0853-0.0008 (-0.93%)
As of 08:11AM BST. Market open.
Full screen
Previous close0.0861
Open0.0853
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0853 - 0.0853
52-week range0.0853 - 0.0853
Volume8
Avg. volumeN/A
Market cap63.151M
Beta (5Y monthly)0.61
PE ratio (TTM)N/A
EPS (TTM)-0.0480
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Evolva successfully placed shares from authorized capital, raising CHF 6.3 million

    Evolva Holding SA / Key word(s): Financing24-May-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc Announcement (PDF)PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Successful private placement with several long-term oriented institutional investors, underlining trust in new leadership team Selected Board members and management personally participated with CHF 1.0 million, demonstra

  • EQS Group

    Evolva business update: On track to reach 2022 guidance

    Evolva Holding SA / Key word(s): Miscellaneous19-May-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc Announcement (PDF)PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva is on track to reach its targeted revenue growth of 50% in 2022 and a positive, double-digit gross contribution margin The two recently announced customer orders above the CHF 1 million threshold underline the

  • EQS Group

    Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil

    Evolva Holding SA / Key word(s): Agreement/Development of Sales12-May-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc Announcement (PDF)PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Distribution agreement signed with Tovani Benzaquen Ingredients to jointly develop the Brazilian business Minimum revenues of CHF 1.5 million expected from the partnership Reinach, May 12, 2022 – Evo